
AI is about to change healthcare. These 7 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
For Hemlo Mining, the investment case now really comes down to whether you believe this freshly profitable, newly listed TSX producer can turn a strong first half into something more durable. The latest results confirm that the move back into the black is not a one-off quarter, which matters for short term catalysts like balance sheet flexibility after the credit facility repayment, confidence in the expanded Hemlo resource base and how the market treats a still-expensive earnings multiple. At the same time, the quality and repeatability of earnings remain open questions, especially with a young board and management team and prior one-off items still in the rear-view mirror. The recent news fits neatly into that tension: improved profitability, but execution risk is still front and center.
However, the company’s premium valuation leaves less room for operational missteps that investors should understand. Hemlo Mining's shares have been on the rise but are still potentially undervalued by 42%. Find out what it's worth.Explore another fair value estimate on Hemlo Mining - why the stock might be worth as much as 29% more than the current price!
Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com